Lymphovascular Invasion as a Prognostic Factor in Non-Metastatic Adenocarcinoma of Esophagogastric Junction After Radical Surgery

References

• Kumamoto T, Kurahashi Y, Niwa H, et al. True esophagogastric junction adenocarcinoma: background of its definition and current surgical trends. Surg Today. 2020;50(8):809–814. doi:10.1007/s00595-019-01843-431278583
   PubMed Web of Science ®Google Scholar
• Buas MF, Vaughan TL. Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol. 2013;23(1):3–9. doi:10.1016/j.semradonc.2012.09.00823207041
   PubMed Web of Science ®Google Scholar
• Liu K, Yang K, Zhang W, et al. Changes of esophagogastric junctional adenocarcinoma and gastroesophageal reflux disease among surgical patients during 1988–2012. Ann Surg. 2016;263(1):88–95. doi:10.1097/SLA.000000000000114825647058
   PubMed Web of Science ®Google Scholar
• Matsuno K, Ishihara R, Ohmori M, et al. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma. J Gastroenterol. 2019;54(9):784–791. doi:10.1007/s00535-019-01577-730927083
   PubMed Web of Science ®Google Scholar
• Lee JH, Chang KK, Yoon C, et al. Lauren histologic type is the most important factor associated with pattern of recurrence following resection of gastric adenocarcinoma. Ann Surg. 2018;267(1):105–113. doi:10.1097/SLA.000000000000204027759618
   PubMed Web of Science ®Google Scholar
• Hosokawa Y, Kinoshita T, Konishi M, et al. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan. Ann Surg Oncol. 2012;19(2):677–683. doi:10.1245/s10434-011-1983-x21822549
   PubMed Web of Science ®Google Scholar
• Urabe M, Ushiku T, Shinozaki-Ushiku A, et al. Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: a comparative analysis according to Siewert classification in a Japanese cohort. Cancer Med. 2018;7(10):5145–5154. doi:10.1002/cam4.176330239168
   PubMed Web of Science ®Google Scholar
• Ishihara R, Oyama T, Abe S, et al. Risk of metastasis in adenocarcinoma of the esophagus: a multicenter retrospective study in a Japanese population. J Gastroenterol. 2017;52(7):800–808.27757547
   PubMed Web of Science ®Google Scholar
• Davies AR, Sandhu H, Pillai A, et al. Surgical resection strategy and the influence of radicality on outcomes in oesophageal cancer. Br J Surg. 2014;101(5):511–517. doi:10.1002/bjs.945624615656
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen X, Wang S, Fan J, Lu L. Poorer prognosis associated with simultaneous lymphatic and vascular invasion in patients with squamous carcinoma of the thoracic oesophagus. Eur j Cardio Thoracic Surg. 2017;52(2):378–384. doi:10.1093/ejcts/ezx081
   PubMed Web of Science ®Google Scholar
• Zhang CD, Ning FL, Zeng XT, Dai DQ. Lymphovascular invasion as a predictor for lymph node metastasis and a prognostic factor in gastric cancer patients under 70 years of age: a retrospective analysis. Int j Surg. 2018;53214.
   Web of Science ®Google Scholar
• Ji X, Yan Y, Bu Z-D, et al. The optimal extent of gastrectomy for middle-third gastric cancer: distal subtotal gastrectomy is superior to total gastrectomy in short-term effect without sacrificing long-term survival. BMC Cancer. 2017;17(1):345. doi:10.1186/s12885-017-3343-028526077
   PubMedGoogle Scholar
• Liu E, Zhong M, Xu F, et al. Impact of lymphatic vessel invasion on survival in curative resected gastric cancer. J Gastrointestinal Surg. 2011;15(9):1526–1531. doi:10.1007/s11605-011-1600-0
   PubMed Web of Science ®Google Scholar
• von Rahden BHA, Stein HJ, Feith M, Becker K, Siewert JR. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction. J clin oncol. 2005;23(4):874–879. doi:10.1200/JCO.2005.12.15115681533
   PubMed Web of Science ®Google Scholar
• Hsu P-K, Chien L-I, Wang L-C, Chou T-Y. Lymphovascular invasion and extracapsular invasion are risk factors for distant recurrence after preoperative chemoradiotherapy and oesophagectomy in patients with oesophageal squamous cell carcinoma. Eur j Cardio Thoracic Surg. 2017;51(6):1188–1194. doi:10.1093/ejcts/ezx029
   PubMed Web of Science ®Google Scholar
• Lee J-H, Kim J-H, Choi J-W, Kim Y-SKJ. The presence of a micropapillary component predicts aggressive behaviour in early and advanced gastric adenocarcinomas. Pathology. 2010;42(6):560–563. doi:10.3109/00313025.2010.50879020854075
   PubMed Web of Science ®Google Scholar
• Lu J, Dai Y, Xie J-W, et al. Combination of lymphovascular invasion and the AJCC TNM staging system improves prediction of prognosis in N0 stage gastric cancer: results from a high-volume institution. BMC Cancer. 2019;19(1):216. doi:10.1186/s12885-019-5416-830857518
   PubMedGoogle Scholar
• Pei Q, Zhu H, Tan F, et al. Intravascular emboli is an independent risk factor for the prognosis of stage III colorectal cancer patients after radical surgery. Oncotarget. 2016;7(35):57268–57276. doi:10.18632/oncotarget.1126627528226
   PubMedGoogle Scholar
• Hsu CP, Chuang CY, Hsu PK, et al. Lymphovascular invasion as the major prognostic factor in node-negative esophageal cancer after primary esophagectomy. J Gastrointestinal Surg. 2019;1:25.
   Google Scholar
• Lagarde SM, Ten Kate FJW, Reitsma JB, Busch ORC, van Lanschot JJ. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J clin oncol. 2006;24(26):4347–4355. doi:10.1200/JCO.2005.04.944516963732
   PubMed Web of Science ®Google Scholar
• Zhang Y-F. Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus. World j Gastroenterology. 2012;18(27):3602–3609. doi:10.3748/wjg.v18.i27.3602
   PubMed Web of Science ®Google Scholar
• Siewert J, Feith M, Werner M, Stein H. Wong Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients. Ann Surg. 2000;232(3):353–361. doi:10.1097/00000658-200009000-0000710973385
   PubMed Web of Science ®Google Scholar
• Rice TW, Ishwaran H, Hofstetter WL, et al. Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus. 2016;29(8):897–905. doi:10.1111/dote.1253327905172
   PubMed Web of Science ®Google Scholar
• Amin MB, et al. AJCC Cancer Staging Manual (8th Ed) [M]. New York: Springer; 2017:185–202.
   Google Scholar
• Yamada M, Kushima R, Oda I, et al. Different histological status of gastritis in superficial adenocarcinoma of the esophagogastric junction. Jpn J Clin Oncol. 2014;44(1):65–71. doi:10.1093/jjco/hyt16724220802
   PubMed Web of Science ®Google Scholar
• de Jonge PJF, van Blankenstein M, Grady WM, Kuipers Barrett’s EJ. Barrett’s oesophagus: epidemiology, cancer risk and implications for management. Gut. 2014;63(1):191–202. doi:10.1136/gutjnl-2013-30549024092861
   PubMed Web of Science ®Google Scholar
• Gertler R, Stein HJ, Schuster T, et al. Prevalence and topography of lymph node metastases in early esophageal and gastric cancer. Ann Surg. 2014;259(1):96–101. doi:10.1097/SLA.000000000000023924096772
   PubMed Web of Science ®Google Scholar
• Pyo JH, Lee H, Min YW, et al. Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with Siewert type II/III early gastric cancer. Gastric Cancer. 2018;21(4):672–679. doi:10.1007/s10120-017-0789-329243195
   PubMed Web of Science ®Google Scholar
• Min B-H, Byeon S-J, Lee JH, et al. Lymphovascular invasion and lymph node metastasis rates in papillary adenocarcinoma of the stomach: implications for endoscopic resection. Gastric Cancer. 2018;21(4):680–688. doi:10.1007/s10120-017-0785-729280035
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen P, Wang F, Lin L. Lymphovascular invasion as an independent prognostic indicator in radically resected thoracic esophageal squamous cell carcinoma. Thoracic Cancer. 2019;10(2):150–155.30484962
   PubMed Web of Science ®Google Scholar
• Kukko HM, Koljonen VSK, Tukiainen EJ, Haglund CH, Bohling TO. Vascular invasion is an early event in pathogenesis of Merkel cell carcinoma. Modern Pathol. 2010;23(8):1151–1156. doi:10.1038/modpathol.2010.100
   PubMed Web of Science ®Google Scholar
• Mahooti S, Porter K, Alpaugh ML, et al. Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion. Oncotarget. 2010;1(2):131–147. doi:10.18632/oncotarget.11721297224
   PubMedGoogle Scholar
• Tomlinson JS, Alpaugh ML, Barsky SH. An intact overexpressed E-cadherin/alpha, beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res. 2001;61(13):5231–5241.11431364
   PubMed Web of Science ®Google Scholar
• Ye Y, Tian H, Lange AR, et al. The genesis and unique properties of the lymphovascular tumor embolus are because of calpain-regulated proteolysis of E-cadherin. Oncogene. 2013;32(13):1702–1713. doi:10.1038/onc.2012.18022580607
   PubMed Web of Science ®Google Scholar